Browsing by Author "Parikh, Suhag"
Now showing items 1-5 of 5
-
Allogeneic stem cell transplantation with omidubicel in sickle cell disease.
Parikh, Suhag; Brochstein, Joel A; Galamidi, Einat; Schwarzbach, Aurélie; Kurtzberg, Joanne (Blood advances, 2021-02)Many patients with sickle cell disease (SCD) do not have HLA-matched related donors for hematopoietic stem cell transplantation (HSCT). Unrelated cord blood (UCB) is an alternative graft option but is historically associated ... -
Immune Reconstitution and Survival of 100 SCID Patients Post Hematopoietic Cell Transplant: A PIDTC Natural History Study.
Heimall, Jennifer; Logan, Brent R; Cowan, Morton J; Notarangelo, Luigi D; Griffith, Linda M; Puck, Jennifer M; Kohn, Donald B; ... (37 authors) (Blood, 2017-10-11)The Primary Immune Deficiency Treatment Consortium (PIDTC) is enrolling children with severe combined immunodeficiency (SCID) to a prospective natural history study. We analyzed patients treated with allogeneic hematopoietic ... -
Long-Term Functional Outcomes following Hematopoietic Stem Cell Transplant for Early Infantile Krabbe Disease.
Allewelt, Heather; Taskindoust, Mahsa; Troy, Jesse; Page, Kristin; Wood, Susan; Parikh, Suhag; Prasad, Vinod K; ... (8 authors) (Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2018-06-19)Allogeneic hematopoietic stem cell transplantation (HSCT) can retard the progression of early infantile Krabbe disease (EIKD). Superior outcomes are achieved if HSCT is performed prior to the onset of symptoms, however little ... -
Outcome of Hematopoietic Cell Transplantation for DNA-Double Strand Breakage Repair Disorders.
Slack, James; Albert, Michael H; Balashov, Dmitry; Belohradsky, Bernd H; Bertaina, Alice; Bleesing, Jack; Booth, Claire; ... (55 authors) (J Allergy Clin Immunol, 2017-04-06)BACKGROUND: Rare DNA breakage-repair disorders predispose to infection and lympho-reticular malignancies. Hematopoietic cell transplantation (HCT) is curative but co-administered chemo- or radio-therapy is damaging due to ... -
Use of Letermovir for Salvage Therapy for Resistant Cytomegalovirus in a Pediatric Hematopoietic Stem Cell Transplant Recipient.
Kilgore, Jacob T; Becken, Bradford; Varga, Matthew G; Parikh, Suhag; Prasad, Vinod; Lugo, Debra; Chang, Yeh-Chung (Journal of the Pediatric Infectious Diseases Society, 2019-07-31)We present here the first published use of letermovir for the treatment of resistant cytomegalovirus (CMV) in a pediatric patient. A 14-year-old girl underwent a double unrelated umbilical cord blood transplantation to treat ...